Reckitt Benckiser Group (LON:RB) Price Target Cut to GBX 6,400
Reckitt Benckiser Group (LON:RB) had its price objective reduced by equities research analysts at Barclays from GBX 6,700 ($88.13) to GBX 6,400 ($84.19) in a note issued to investors on Tuesday, Borsen Zeitung reports. The brokerage currently has a “buy” rating on the stock. Barclays‘s target price suggests a potential upside of 3.68% from the company’s previous close.
A number of other research firms have also issued reports on RB. Deutsche Bank reissued a “buy” rating and set a GBX 7,200 ($94.71) price target on shares of Reckitt Benckiser Group in a research report on Thursday, February 27th. Goldman Sachs Group raised their price target on shares of Reckitt Benckiser Group from GBX 5,800 ($76.30) to GBX 6,000 ($78.93) and gave the stock a “neutral” rating in a research report on Tuesday. UBS Group reduced their price target on shares of Reckitt Benckiser Group from GBX 6,100 ($80.24) to GBX 5,700 ($74.98) and set a “neutral” rating for the company in a research report on Wednesday, March 4th. Kepler Capital Markets reduced their price target on shares of Reckitt Benckiser Group from GBX 6,950 ($91.42) to GBX 6,600 ($86.82) and set a “buy” rating for the company in a research report on Tuesday, March 3rd. Finally, Morgan Stanley reissued a “buy” rating and set a GBX 6,600 ($86.82) price target on shares of Reckitt Benckiser Group in a research report on Monday. Three investment analysts have rated the stock with a sell rating, five have given a hold rating and eleven have issued a buy rating to the company. The stock has a consensus rating of “Hold” and a consensus price target of GBX 6,355 ($83.60).
RB traded up GBX 223 ($2.93) during trading on Tuesday, reaching GBX 6,173 ($81.20). 4,044,904 shares of the company’s stock were exchanged, compared to its average volume of 1,720,000. Reckitt Benckiser Group has a 1 year low of GBX 5,510 ($72.48) and a 1 year high of GBX 8,191.30 ($107.75). The company has a debt-to-equity ratio of 130.80, a current ratio of 0.56 and a quick ratio of 0.41. The stock has a market capitalization of $44.22 billion and a P/E ratio of -11.88. The company’s fifty day simple moving average is GBX 6,093.46 and its 200-day simple moving average is GBX 6,103.72.
About Reckitt Benckiser Group
Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.
Featured Story: What is the Russell 2000 Index?
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.